Andrew Sloan, MD, Neurosurgery, Cleveland, OH, UH Cleveland Medical Center

AndrewSloanMD

Neurosurgery Cleveland, OH

Brain & Spinal Tumor, Neurosurgical Spine Surgery, Pituitary Surgery

Professor & Vice-Chair of Neurological Surgery; Peter D. Cristal Chair of Neurosurgical Oncology; Director, Center for Brain Tumor & Neuro-Oncology; Director, Center of Excellence in Translational Neuro-Oncology; University Hospitals & Seidman Cancer Center Case Comprehensive Cancer Center, & Case Western Reserve University School of Medicine

Dr. Sloan is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sloan's full profile

Already have an account?

Education & Training

  • UCLA Medical Center
    UCLA Medical CenterResidency, Neurological Surgery, 1990 - 1997
  • Harvard Medical School
    Harvard Medical SchoolClass of 1990

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2006 - 2022
  • FL State Medical License
    FL State Medical License 2004 - 2022
  • MI State Medical License
    MI State Medical License 1998 - 2023
  • CA State Medical License
    CA State Medical License 1992 - 2021
  • American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Fellow (FAANS) American Association of Neurological Surgeons
  • Fellow (FACS) American College of Surgeons
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • NRG BN002: Phase I study of checkpoint inhibitors anti-CTLA-4, anti-PD-1, the combination in patients with newly diagnosed glioblastoma. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
  • Phase I/II study of laser interstitial thermotherapy (LITT) combined with checkpoint inhibitor for recurrent glioblastoma (rGBM). 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • Medtronic Selects UH Cleveland Medical Center for Stealth Autoguide Precision Robotic Platform for Brain Surgery
    Medtronic Selects UH Cleveland Medical Center for Stealth Autoguide Precision Robotic Platform for Brain SurgeryNovember 11th, 2020
  • Bevacizumab for the Treatment of Non-Small Cell Lung Cancer Patients with Synchronous Brain Metastases
    Bevacizumab for the Treatment of Non-Small Cell Lung Cancer Patients with Synchronous Brain MetastasesNovember 28th, 2019
  • Pascal Biosciences – New Cancer Treatments Emerging from Pioneering Cannabinoid Discoveries
    Pascal Biosciences – New Cancer Treatments Emerging from Pioneering Cannabinoid DiscoveriesJuly 23rd, 2019
  • Join now to see all

Committees

  • Member, Committee on Appropriateness Criteria, Expert Panel on Musculoskeletal Imaging, American College of Radiology 2015 - Present

Professional Memberships

Hospital Affiliations